Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Scarpi

Showing results (91-100 of 215) with videos related to

Pageof 22
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2017
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamidePaola Caroli, Ugo De Giorgi, Emanuela Scarpi, et al.
Cancer Management and Research|December 12, 2018
IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumabGiorgia Marisi, Emanuela Scarpi, Alessandro Passardi, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 20, 2008
Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancerDaniele Calistri, Claudia Rengucci, Chiara Molinari, et al.
Journal of Cancer|June 7, 2012
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and ChemotherapyGiovenzio Genestreti, Andrea Moretti, Sara Piciucchi, et al.
Technology in Cancer Research & Treatment|June 20, 2014
Endobronchial/Endoesophageal Ultrasound (EBUS/EUS) Guided Fine Needle Aspiration (FNA) and 18F-FDG PET/CT Scanning in Restaging of Locally Advanced Non-small Cell Lung Cancer (NSCLC) Treated with Chemo-radiotherapy: A Mono-institutional Pilot ExperienceGiovenzio Genestreti, Marco Angelo Burgio, Federica Matteucci, et al.
Hepato-Gastroenterology|June 14, 2011
GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancerCarlo Milandri, Rolando Polico, Domenico Garcea, et al.
Breast Cancer Research and Treatment|December 20, 2007
Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutationsIan J Seymour, Silvia Casadei, Valentina Zampiga, et al.
Scientific Reports|May 4, 2017
Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumabGiorgia Marisi, Emanuela Scarpi, Alessandro Passardi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 17, 2007
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapyDavide Tassinari, Luigi Montanari, Marco Maltoni, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer PatientsSamanta Salvi, Erika Bandini, Silvia Carloni, et al.
Pageof 22

Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2017
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamidePaola Caroli, Ugo De Giorgi, Emanuela Scarpi, et al.
Cancer Management and Research|December 12, 2018
IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumabGiorgia Marisi, Emanuela Scarpi, Alessandro Passardi, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 20, 2008
Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancerDaniele Calistri, Claudia Rengucci, Chiara Molinari, et al.
Journal of Cancer|June 7, 2012
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and ChemotherapyGiovenzio Genestreti, Andrea Moretti, Sara Piciucchi, et al.
Technology in Cancer Research & Treatment|June 20, 2014
Endobronchial/Endoesophageal Ultrasound (EBUS/EUS) Guided Fine Needle Aspiration (FNA) and 18F-FDG PET/CT Scanning in Restaging of Locally Advanced Non-small Cell Lung Cancer (NSCLC) Treated with Chemo-radiotherapy: A Mono-institutional Pilot ExperienceGiovenzio Genestreti, Marco Angelo Burgio, Federica Matteucci, et al.
Hepato-Gastroenterology|June 14, 2011
GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancerCarlo Milandri, Rolando Polico, Domenico Garcea, et al.
Breast Cancer Research and Treatment|December 20, 2007
Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutationsIan J Seymour, Silvia Casadei, Valentina Zampiga, et al.
Scientific Reports|May 4, 2017
Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumabGiorgia Marisi, Emanuela Scarpi, Alessandro Passardi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 17, 2007
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapyDavide Tassinari, Luigi Montanari, Marco Maltoni, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer PatientsSamanta Salvi, Erika Bandini, Silvia Carloni, et al.
Pageof 22